Tokyo - Gene Techno Science Co., Ltd. ('GTS') executed a joint research agreement ('this agreement') with Hokkaido University and Spinal Injuries Center for a development of new therapy for non-union fractures.

Since non-union fractures are especially common in the elderly people and cause bedridden and long-term care, it is an urgent social need to develop new treatment methods. Regenerative medicine using stem cells has been researching as a candidate of new treatment methods, but among them, our stem cells from human exfoliated deciduous teeth are younger in donor age and are expected to have excellent bone regenerating ability. In this joint research, we focus on developing new treatment methods for the regeneration of bones for the elderly with stem cells from human exfoliated deciduous teeth.

The impact on the business results for the fiscal year ending March 2021 is expected to be minimal.

About Gene Techno Science Co., Ltd.

GTS announced GTS 3.0 'Biotech Engineering Company, striving for value creation' a new business stage starting from this fiscal year, which targeted the pediatric disease in addition to the areas GTS has been engaged in such as the orphan disease and intractable disease. By leveraging the knowhow and expertise about biotechnology acquired in the past business activities, GTS is working on the development and provision of new medicines and therapeutic treatment for the purpose of achieving comprehensive healthcare solutions for the patients suffering from these diseases as well as families and caregivers.

Contact:

Tel: +81-3-6222-9547

Email: info@g-gts.com

(C) 2020 Electronic News Publishing, source ENP Newswire